3.825
前日終値:
$3.81
開ける:
$3.75
24時間の取引高:
872.20K
Relative Volume:
0.90
時価総額:
$217.93M
収益:
-
当期純損益:
$-82.44M
株価収益率:
-2.0346
EPS:
-1.88
ネットキャッシュフロー:
$-66.75M
1週間 パフォーマンス:
-4.38%
1か月 パフォーマンス:
-3.17%
6か月 パフォーマンス:
+88.88%
1年 パフォーマンス:
+57.79%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
名前
Black Diamond Therapeutics Inc
セクター
電話
617-417-5868
住所
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BDTX
Black Diamond Therapeutics Inc
|
3.825 | 217.07M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.01 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.11 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.15 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.22 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 再開されました | Piper Sandler | Overweight |
| 2025-10-16 | 再開されました | Stifel | Buy |
| 2025-09-04 | 開始されました | Guggenheim | Buy |
| 2025-07-01 | 再開されました | Raymond James | Outperform |
| 2024-07-31 | 開始されました | Raymond James | Outperform |
| 2023-07-14 | 開始されました | Piper Sandler | Overweight |
| 2023-06-30 | アップグレード | Stifel | Hold → Buy |
| 2023-06-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-03-29 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-03-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 開始されました | Stifel | Hold |
| 2021-01-07 | 開始されました | Wedbush | Outperform |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2020-02-24 | 開始されました | Canaccord Genuity | Buy |
| 2020-02-24 | 開始されました | Cowen | Outperform |
| 2020-02-24 | 開始されました | JP Morgan | Overweight |
| 2020-02-24 | 開始されました | Jefferies | Buy |
すべてを表示
Black Diamond Therapeutics Inc (BDTX) 最新ニュース
What insider trading reveals about Black Diamond Therapeutics Inc. stockQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Black Diamond Therapeutics: Underappreciated Despite An Upcoming Key Readout (NASDAQ:BDTX) - Seeking Alpha
Will Black Diamond Therapeutics Inc. stock pay special dividends2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Piper Sandler - Defense World
Can Black Diamond Therapeutics Inc. stock hit record highs againJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Will Black Diamond Therapeutics Inc. stock maintain momentum in 2025July 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Volume spikes in Black Diamond Therapeutics Inc. stock – what they meanQuarterly Growth Report & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
It makes sense and dollars to buy Black Diamond Therapeutics Inc (BDTX) stock - Setenews
How to read the order book for Black Diamond Therapeutics Inc.Earnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Piper Sandler Assumes Coverage on BDTX with Overweight Rating | BDTX Stock News - GuruFocus
Tools to assess Black Diamond Therapeutics Inc.’s risk profileMarket Rally & Weekly Market Pulse Updates - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
15,800 Shares in Black Diamond Therapeutics, Inc. $BDTX Bought by Bailard Inc. - Defense World
Is Black Diamond Therapeutics Inc. trending in predictive chart models2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explainedProfit Target & Risk Managed Investment Strategies - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO) - The Globe and Mail
Black Diamond Therapeutics files for mixed shelf of up to $500 millionSEC filing - MarketScreener
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Black Diamond Therapeutics Inc (BDTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):